SPH SINCLAIR PHARMA PLC ORD 1P
We are now using data from FTSE Russell Data Solutions. FTSE Russell is a leading global provider of benchmarks, analytics and data solutions with multi-asset capabilities. Global Company Fundamentals provides profiles on global active and inactive companies from over 100 countries including over 25 years of as-reported financials and standardised financials based on globally accepted XBRL taxonomies for active companies. As a result of this change in data provider, you may see some differences to the data. For further information please contact lse-website@lseg.com
| Income Statement |
30-Jun-12 ( £ m ) |
30-Jun-13 ( £ m ) |
30-Jun-14 ( £ m ) |
30-Jun-15 ( £ m ) |
31-Dec-16 ( £ m ) |
|---|---|---|---|---|---|
| Continuing Operations | |||||
| Revenue | 51.42 | 55.38 | 63.56 | 75.89 | 45.49 |
| Operating Profit/(Loss) | -8.49 | -15.33 | -1.78 | 4.54 | -18.24 |
| Net Interest | -1.17 | -0.90 | -3.92 | -14.46 | -11.14 |
| Profit Before Tax | -9.77 | -16.98 | -4.44 | -8.15 | -34.03 |
| Profit After Tax | -8.64 | -15.85 | -4.09 | -7.21 | -33.40 |
| Discontinued Operations | |||||
| Profit After Tax | n/a | -1.52 | -1.21 | n/a | 3.82 |
| PROFIT FOR THE PERIOD | -8.64 | -17.36 | -5.30 | -7.21 | -29.58 |
| Attributable to: | |||||
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Equity Holders of Parent Company | -8.64 | -17.36 | -5.30 | -7.21 | -29.58 |
| Continuing EPS | |||||
| Earnings per Share - Basic | -2.20p | -3.70p | -0.90p | -1.50p | -6.70p |
| Earnings per Share - Diluted | -2.20p | -3.70p | -0.90p | -1.50p | -6.70p |
| Earnings per Share - Adjusted | n/a | n/a | n/a | n/a | n/a |
| Continuing and Discontinued EPS | |||||
| Earnings per Share - Basic | -2.20p | -4.10p | -1.20p | -1.50p | -5.90p |
| Earnings per Share - Diluted | -2.20p | -4.10p | -1.20p | -1.50p | -5.90p |
| Earnings per Share - Adjusted | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share | n/a | n/a | n/a | n/a | n/a |
| Balance Sheet |
30-Jun-12 ( £ m ) |
30-Jun-13 ( £ m ) |
30-Jun-14 ( £ m ) |
30-Jun-15 ( £ m ) |
31-Dec-16 ( £ m ) |
|---|---|---|---|---|---|
| Assets | |||||
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0.84 | 0.50 | 1.40 | 1.71 | 1.68 |
| Intangible Assets | 129.62 | 121.36 | 241.54 | 232.28 | 148.88 |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Investments | n/a | 0.16 | 0.16 | 0.17 | 0.10 |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| 135.83 | 126.17 | 248.05 | 237.47 | 150.66 | |
| Current Assets | |||||
| Inventories | 5.83 | 4.85 | 7.60 | 7.62 | 3.84 |
| Trade & Other Receivables | 16.78 | 19.94 | 27.51 | 26.02 | 13.33 |
| Cash at Bank & in Hand | 4.04 | 5.06 | 17.53 | 12.66 | 16.77 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 26.65 | 29.84 | 54.67 | 47.95 | 33.94 | |
| Total Assets | 162.48 | 156.02 | 302.72 | 285.42 | 184.60 |
| Liabilities | |||||
| Current Liabilities | |||||
| Borrowings | 3.12 | 3.42 | 1.24 | 0.02 | n/a |
| Other Current Liabilities | 3.84 | 11.94 | 27.01 | 34.15 | 22.00 |
| 20.46 | 24.03 | 42.88 | 46.75 | 26.88 | |
| Net Current Assets | 6.19 | 5.82 | 11.79 | 1.20 | 7.06 |
| Non-Current Liabilities | |||||
| Borrowings | 9.98 | 8.50 | 53.32 | 51.78 | 0.00 |
| Provisions | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Liabilities | 4.46 | 2.02 | 61.57 | 54.62 | 33.32 |
| 27.74 | 21.45 | 141.93 | 133.10 | 57.40 | |
| Other Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Liabilities | 48.20 | 45.48 | 184.80 | 179.84 | 84.28 |
| Net Assets | 114.28 | 110.54 | 117.92 | 105.57 | 100.32 |
| Capital & Reserves | |||||
| Share Capital | n/a | n/a | n/a | n/a | n/a |
| Share Premium Account | 58.73 | 67.24 | 86.14 | 86.13 | 86.13 |
| Other Reserves | n/a | n/a | n/a | n/a | n/a |
| Retained Earnings | -49.14 | -65.88 | -70.16 | -75.94 | -103.29 |
| Shareholders Funds | 114.28 | 110.54 | 117.92 | 105.57 | 100.32 |
| Minority Interests/Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity * | 114.28 | 110.54 | 117.92 | 105.57 | 100.32 |
| Ratios - based on IFRS | 30-Jun-12 | 30-Jun-13 | 30-Jun-14 | 30-Jun-15 | 31-Dec-16 |
|---|---|---|---|---|---|
| Continuing Operations | |||||
| PE Ratio * | n/a | n/a | n/a | n/a | n/a |
| PEG * | n/a | n/a | n/a | n/a | n/a |
| Earnings per Share Growth | n/a | n/a | n/a | n/a | n/a |
| Dividend Cover * | n/a | n/a | n/a | n/a | n/a |
| Revenue Per Share | 13.10p | 12.98p | 14.29p | 15.27p | 6.06p |
| Pre-Tax Profit per Share | -2.49p | -3.98p | -1.00p | -1.64p | -4.54p |
| Operating Margin | -16.51% | -27.68% | -2.81% | 5.99% | -40.09% |
| Return on Capital Employed | -6.48% | -12.27% | -1.21% | 2.75% | -9.39% |
| Continuing & Discontinued Operations | |||||
| Dividend Yield * | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a | n/a | n/a | n/a | n/a |
| Net Asset Value per Share (exc. Intangibles) | -3.81p | -2.49p | -24.85p | -25.47p | -9.67p |
| Net Gearing * | 7.93% | 6.20% | 31.40% | 37.07% | n/a |
Data provided by FTSE Russell
Company Information
| Updated Monthly | |
|---|---|
| Company address | 1st Floor, Whitfield Court, 30-32 Whitfield Street, London, W1T 2RQ, United Kingdom |
| Company website | http://www.sinclairphar... |
| Market cap(in millions)* | £ 93.70 |
| Listing/Admission to trading | 16 Apr 2007 |
| Trading service | SETS |
| Market | AIM |
| Listing category | - |
Trading Information
| 21-Apr-18 | |
|---|---|
| FTSE index | FTSE AIM All-Share,FTSE AIM All-Share - Health Care |
| FTSE sector | Pharmaceuticals & Biotechnology |
| FTSE sub-sector | Pharmaceuticals |
| Country of share register | GB |
| Segment | AMSM |
| MiFID Status | - |
| Exchange market size | 10,000 |
| SEDOL | 3385674 |
| ISIN number | GB0033856740 |